Who
August J. Troendle
President & CEO
Company insider
Files Form 4 as: President & CEO, Medpace Holdings; Director, Coherus Oncology.
In numbers
- Trades disclosed
- 389
- Buys
- 19
- Sells
- 246
- Bought
- $174.8M
- Sold
- $1.7B
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 12 Nov 2014
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $13.7M21,966 at $625.47 | filing |
| 29 Sep 2026filed 1 Oct 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $16.6M26,701 at $621.02 | filing |
| 28 Sep 2026filed 29 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $1.5M2,410 at $620.07 | filing |
| 28 Sep 2026filed 29 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $1.5M2,410 at $620.07 | filing |
| 25 Sep 2026filed 29 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $96K154 at $620.60 | filing |
| 25 Sep 2026filed 29 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $96K154 at $620.60 | filing |
| 24 Sep 2026filed 25 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $17.3M27,833 at $621.33 | filing |
| 24 Sep 2026filed 25 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $17.3M27,833 at $621.33 | filing |
| 23 Sep 2026filed 25 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $10.1M16,083 at $628.64 | filing |
| 23 Sep 2026filed 25 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $10.1M16,083 at $628.64 | filing |
| 22 Sep 2026filed 23 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $30.8M49,018 at $628.11 | filing |
| 22 Sep 2026filed 23 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $30.8M49,018 at $628.11 | filing |
| 21 Sep 2026filed 23 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $13.6M21,883 at $623.29 | filing |
| 21 Sep 2026filed 23 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $13.6M21,883 at $623.29 | filing |
| 17 Sep 2026filed 21 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $6.7M10,880 at $620.40 | filing |
| 17 Sep 2026filed 21 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $6.7M10,880 at $620.40 | filing |
| 16 Sep 2026filed 17 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $5.4M8,770 at $621.29 | filing |
| 16 Sep 2026filed 17 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $5.4M8,770 at $621.29 | filing |
| 15 Sep 2026filed 17 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $9.9M15,971 at $620.84 | filing |
| 15 Sep 2026filed 17 Sep 2026 | MEDP Medpace HoldingsLife-science tools | SEC FORM 4 Sold | $9.9M15,971 at $620.84 | filing |
News
Medpace Holdings, Inc. Profit Climbs In Q3MEDP · finanzen.ch · 22 Oct 2026Medpace Stock Slips Despite Solid Report; Where Are The 'Holes?'MEDP · investors.com · 22 Oct 2026Head to Head Comparison: Bio-Rad Laboratories (NYSE:BIO) versus Medpace (NASDAQ:MEDP)MEDP · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name August J. Troendle; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.